Durable complete response to PET-CT driven stereotactic radiation therapy plus pembrolizumab for pleomorphic Pancoast cancer: Case report and literature review

Clin Case Rep. 2024 Apr 5;12(4):e8633. doi: 10.1002/ccr3.8633. eCollection 2024 Apr.ABSTRACTPET-driven SBRT plus pembrolizumab as first-line therapy against pleomorphic Pancoast cancer appears beneficial, probably due to high equivalent doses of SBRT on photopenic necrotic core and synergic immune system stimulation of immunoradiotherapy.PMID:38585585 | PMC:PMC10996042 | DOI:10.1002/ccr3.8633

Source: Clinical Lung Cancer - April 8, 2024 Category: Cancer & Oncology Authors: Alessandra Castelluccia Angela Sardaro Artor Niccoli Asabella Antonio Rosario Pisani Dino Rubini Maurizio Portaluri Francesco Tramacere Source Type: research